The pattern of anti-IL-6 versus non-anti-IL-6 biologic disease modifying anti-rheumatic drugs use in patients with rheumatoid arthritis in Wales, UK: a real-world study using electronic health records
2024

Use of Anti-IL-6 Biologics in Rheumatoid Arthritis Patients in Wales

Sample size: 4922 publication 10 minutes Evidence: moderate

Author Information

Author(s): Roxanne Cooksey, Jonathan Kennedy, Muhammad Rahman, Sinead Brophy, Ernest Choy

Primary Institution: Cardiff University

Hypothesis

What factors are associated with the initiation and discontinuation of anti-IL-6 biologic DMARDs compared to non-anti-IL-6 biologics in rheumatoid arthritis patients?

Conclusion

Patients treated with anti-IL-6 biologics were more likely to continue treatment than those treated with non-anti-IL-6 biologics.

Supporting Evidence

  • 95.7% of patients received conventional synthetic DMARDs.
  • 36.2% of patients were treated with biologic DMARDs.
  • 6.5% of biologic-naïve patients were treated with anti-IL-6 bDMARDs.
  • Treatment discontinuation was higher in non-anti-IL-6 bDMARD-treated patients.

Takeaway

This study looked at how different medicines help people with arthritis and found that some medicines work better for keeping patients on treatment.

Methodology

A retrospective cohort study using electronic health records from the Secure Anonymised Information Linkage Databank.

Potential Biases

Potential underpowering to detect associations due to low numbers of patients on anti-IL-6 bDMARDs.

Limitations

The cohort may not represent early or less severe rheumatoid arthritis patients, and the absence of certain clinical data may limit findings.

Participant Demographics

Mean age of 62 years, 71.6% female, mean disease duration of 6.3 years.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI 1.1, 17.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/rap/rkae140

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication